Astellas Pharma Takes the Lead in Digital Transformation with Acquia’s Open Source and Cloud Technologies For Unified Website Platform [May 31, 2017]

WIth CI&T, Japan’s pharmaceutical leader works on websites standardisation with Drupal 8, to enable timely and appropriate information disclosure to all stakeholders

Sydney, Australia, May 31, 2017 - Acquia, the digital experience company, announced today that Astellas Pharma Inc. (TSE: 4503, hereinafter "Astellas Pharma"), Japan’s pharmaceutical leader which is a R&D oriented global pharmaceutical company, has adopted Acquia Cloud Site Factory as the unified website platform for its Japanese and global websites.

With digital technology agency partner CI&T Japan Inc. (hereinafter "CI&T"), Astellas Pharma started using Acquia's cloud solutions and Drupal 8 to develop a standardised platform for the development, management and governance of multiple multilingual websites. This unified website platform is a strategic initiative that makes it possible to further strengthen the publication of important information and governance in a more timely, secure and stable manner, regardless of region or language. Today, running on the unified platform, Astellas Pharma has launched its new global website www.astellas.com.

Beginning with its corporate site, Astellas Pharma plans to rebuild all corporate sites of Astellas Group subsidiaries based on its unified platform. This project, supported by CI&T, will drive the "Astellas Way" initiative by executing a digital governance strategy that focuses on key pillars including security, time to market, quality, standardisation, innovation, and user experience.

“By choosing Acquia Cloud Site Factory, we were able to build an IT infrastructure to optimise the system architecture and operation at the global level. We believe that by utilising this service, we were able to achieve the highest level of availability and safety that is essential for timely and appropriate information disclosure to our stakeholders,” said Mr. Shinya Suda, corporate vice president of the information systems at Astellas.

"Japanese companies are increasingly willing to pursue a digital experience globally by making full use of digital technology. As of now, Acquia cloud products together with Drupal 8 have become the platform of choice for high-end digital transformation, as a leader in enterprise CMS in western countries. Now with CI&T joining this trend, Drupal and Acquia will dominate the Japanese market," said Yoshiyuki Ueda, business director of Japan at CI&T.

“We’ve been working hard to establish the Acquia brand and grow the Drupal community, through a strong partner channel in Asia Pacific and Japan, so to see the innovation taking place in a company as large and respected as Astellas Pharma, driven by CI&T, is more than encouraging, it’s exciting. We anticipate great interest from other large enterprises as a result of this, and remain committed to supporting Astellas Pharma and CI&T during this exemplary transformation,” said Darren Watkins, senior director of channel partnerships at Acquia.

On June 7, 2017, in Tokyo at Roppongi Academy Hills, Acquia and CI&T will host “Acquia Day 2017”, a seminar introducing latest technologies and cases of Drupal and Aquia, including a presentation by Astellas Pharma. For details and registration, please refer to http://eventregist.com/e/acquia-day-2017.

Also, Acquia Engage Asia Pacific, a user conference hosted by Acquia will be held first time in Sydney, Australia, on August 23 and 24, 2017. CI&T will provide a presentation as a Gold Sponsor. Furthermore, CI&T was recognised as an Acquia MVP in its most recent recognition of partner innovation.

NOTES TO EDITORS

About Acquia
Acquia is the leading provider of cloud-based, digital experience management solutions. Forward-thinking organisations rely on Acquia to transform the way they can engage with customers -- in a personal and contextual way, across every device and channel. Acquia provides the agility organisations need to embrace new digital business models and speed innovation and time to market. With Acquia, thousands of customers globally including the BBC, Nasdaq, Stanford University, and locally Energy Australia, Flight Centre, Brisbane Airport Corporation and the Australian Government are delivering digital experiences with transformational business impact. For more information, please visit www.acquia.com or phone +61 (0)2 8015 2576.

About Astellas
Astellas Pharma Inc., based in Tokyo, Japan, is a company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. We focus on Urology, Oncology, Immunology, Nephrology and Neuroscience as prioritized therapeutic areas while advancing new therapeutic areas and discovery research leveraging new technologies/modalities. We are also creating new value by combining internal capabilities and external expertise in the medical/healthcare business. Astellas is on the forefront of healthcare change to turn innovative science into value for patients. For more information, please visit our website at https//www.astellas.com/en.

About CI&T
CI&T, the digital technology agency for the world's biggest companies, is a pioneer in the application of lean methodologies and next-gen tech including Machine Learning/AI, Advanced Analytics, Cloud and Mobility. For over 20 years, CI&T has been a trusted partner for the most complex global engagements inside companies including Coca-Cola, Google, Johnson & Johnson, AB-InBev, iHeart Media and Motorola. With over 2,500 digital business experts and engineers in the USA, Brazil, UK, Australia, Japan and China, CI&T is big enough to scale to the needs of Fortune 100 clients yet agile enough to achieve the speed to market today's customers demand. As far as Acquia and Drupal, our team of over 300 Drupal experts (with close to 100 of them in the Asia Pacific and Japan region) along with 40+ Acquia Certified Developers is one of the largest in the world, and has won the Acquia Partner of the Year 2017 APJ. For more information, please visit www.ciandt.com.

All logos, company and product names are trademarks or registered trademarks of their respective owners.